Jack Johnson - Concepedia

Author

Jack Johnson

Also Known As

, J JOHNSON, J Johnson, J. Johnson, J. L. Johnson, J.L Johnson, J.L. Johnson, Jack Johnson, Jack L. Johnson, Jesvin Lia Johnson

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Manitoba Health Sciences Centre GlaxoSmithKline (United States)Concordia University Wisconsin University of Bergen

About

Jack Johnson is an author at University of Manitoba specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Health Sciences	6	6	479
3	Engineering	1	1	11
4	Social Sciences	1	1	186
5	Epidemiology	1	1	141

Jack Johnson

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) George G. Zhanel, Tamiko Hisanaga, Nancy M. Laing, International Journal of Antimicrobial Agents Outpatient Urinary IsolatesAntimicrobial SusceptibilityAntimicrobial Resistance GeneAntibioticsAntimicrobial Stewardship	2006	301
Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006 George G. Zhanel, Mel DeCorby, Nancy M. Laing, Antimicrobial Agents and Chemotherapy	2008	270
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) George G. Zhanel, Tamiko Hisanaga, Nancy M. Laing, International Journal of Antimicrobial Agents UrologyOutpatient Urinary IsolatesHealth SciencesAntibioticsAntimicrobial Stewardship	2005	234
In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) Daryl J. Hoban, Samuel K. Bouchillon, Brian Johnson, Diagnostic Microbiology and Infectious Disease PharmacologySurveillance TrialGlobal Tigecycline EvaluationTest Program	2005	205
Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity Jack Johnson, P P Cohen, Stephanie Kasen, Journal of Psychiatric Research Psychological Co-morbiditiesImpaired FunctioningPsychiatryDissociative DisordersComorbid Psychiatric Disorder	2005	186
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst, Kidney International	2016	175
Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008) George G. Zhanel, Melanie DeCorby, Heather J. Adam, Antimicrobial Agents and Chemotherapy	2010	167
Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002 S. Bouchillon, Brian Johnson, D. Hoban, International Journal of Antimicrobial Agents Vancomycin-resistant Enterococcus FaeciumExtended SpectrumAntibiotic ResistanceBacterial PathogensDrug Resistance	2004	141
In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004) Samuel K. Bouchillon, Daryl J. Hoban, Brian Johnson, Diagnostic Microbiology and Infectious Disease MedicineSurveillance TrialGram-positive Clinical IsolatesTest Program	2005	88
Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation James A. Thorp, D. Ferrette-Smith, Laura Gaston, Obstetrics and Gynecology	1995	51

Page 1